Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Evofem Plans 2019 Refiling For Amphora Based On New 86% Contraception Efficacy

Dec 18 2018

• By Joseph Haas

Closed up finger on keyboard with word CLINICAL TRIALS

Related Content

Keeping Track: Clarus, Agile and Sunovion Look To Bounce Back From CRLs; FDA To Review Rituximab Biosimilar

Jul 02 2017

Deal Watch: Neos Says ‘Thanks, No Thanks’ To Repeated PDL Offer

Nov 01 2017

Related Companies

Evofem Biosciences, Inc.

Neothetics, Inc.

Additional Topics

Business Strategies Clinical Trials Commercial Gynecology & Urology BioPharmaceutical

More from Strategy

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window